adlitterio66339

About adlitterio66339

This author has not yet filled in any details.
So far adlitterio66339 has created 792 blog entries.

6 10, 2025

Shooting Cancer Highlights – Periodic focus on regulatory status of new targeted therapies in oncology

adlitterio663392025-10-06T10:02:16+02:00

6 10, 2025

Diatech Pharmacogenetics will attend the MEDICA Exhibition 2025
Diatech Pharmacogenetics will attend the MEDICA Exhibition 2025

Events, News

Diatech Pharmacogenetics will attend the MEDICA Exhibition 2025

adlitterio663392025-10-06T09:03:30+02:00

11 09, 2025

Diatech Pharmacogenetics will attend the ESPT Congress in Rotterdam
Diatech Pharmacogenetics will attend the ESPT Congress in Rotterdam

Events, News

Diatech Pharmacogenetics will attend the ESPT Congress in Rotterdam

adlitterio663392025-09-11T11:25:02+02:00

11 09, 2025

Join our upcoming webinar: “Unlocking Precision Medicine: The Critical Role of BRCA 1-2 Molecular Testing”
Join our upcoming webinar: “Unlocking Precision Medicine: The Critical Role of BRCA 1-2 Molecular Testing”

News

Join our upcoming webinar: “Unlocking Precision Medicine: The Critical Role of BRCA 1-2 Molecular Testing”

adlitterio663392025-09-11T11:09:50+02:00

4 09, 2025

Shooting Cancer Highlights – Periodic focus on regulatory status of new targeted therapies in oncology

adlitterio663392025-09-04T09:35:10+02:00

1 09, 2025

Diatech Pharmacogenetics will attend the 38th European Congress of Pathology
Diatech Pharmacogenetics will attend the 38th European Congress of Pathology

Events, News

Diatech Pharmacogenetics will attend the 38th European Congress of Pathology

adlitterio663392025-09-01T09:32:46+02:00

28 07, 2025

Vanessa Zambelli et al., High prevalence of potential molecular therapeutic targets in poorly differentiated thyroid carcinoma

adlitterio663392025-07-28T08:53:58+02:00

11 07, 2025

Shooting Cancer Highlights – Periodic focus on regulatory status of new targeted therapies in oncology

adlitterio663392025-09-04T09:35:48+02:00

25 06, 2025

Zhasmina Mihaylova et al., Clinically Based Cetuximab Re-Challenge in Patients with RAS Wild-Type Metastatic Colorectal Cancer and Retrospective Analysis of Liquid Biopsies—Preliminary Data.

adlitterio663392025-06-25T16:31:03+02:00

25 06, 2025

Shooting Cancer – ASCO 2025 Highlights: precision oncology in motion

adlitterio663392025-06-25T14:47:46+02:00